MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
1. Bragar Eagel & Squire investigates claims against MRVI for fiduciary breaches. 2. A class action was filed for failing to disclose revenue recognition issues. 3. MRVI's revenue error resulted in a significant drop in share price. 4. The company postponed its fiscal 2024 earnings due to internal control weaknesses. 5. Investors claim MRVI's positive statements lacked reasonable basis.